🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
this study is to evaluate the potential of DSXS to suppress HPA axis functi...
Status
Completed
Location
Taro Pharmaceuticals USA Inc.
Start Date
2015-08-28
Trial ID
NCT02595008
Treatments Being Tested
An Open Label, Safety Study to Assess the Potential for Adrenal Suppression...
Status
Completed
Location
Taro Pharmaceuticals USA, Inc.
Start Date
2016-07-11
Trial ID
NCT02933528
Treatments Being Tested
A Randomized Double-Blind, Vehicle-Controlled, Parallel Design, Multiple-Si...
Status
Completed
Location
Multiple Locations
Start Date
2016-03
Trial ID
NCT02932462
An Open Label, Safety Study to Assess the Potential for Adrenal Suppression...
Status
Completed
Location
Taro Pharmaceuticals USA Inc.
Start Date
2016-08
Trial ID
NCT02932891
Treatments Being Tested
The purpose of this study is to evaluate the therapeutic efficacy and safet...
Status
Completed
Location
Taro Pharmaceuticals USA Inc.
Start Date
2015-08-28
Trial ID
NCT02618759
An Open-Label, Safety Study to Assess the Potential for Adrenal Suppression...
Status
Completed
Location
Taro Pharmaceuticals USA Inc.
Start Date
2016-07-11
Trial ID
NCT02933502
Treatments Being Tested
A Randomized, Double-Blind, Vehicle-Controlled, Parallel-Design, Multiple-S...
Status
Completed
Location
Taro Pharmaceuticals USA, Inc.
Start Date
2016-03-11
Trial ID
NCT02933866
Treatments Being Tested
An Open Label, Safety Study to Assess the Potential for Adrenal Suppression...
Status
Completed
Location
Taro Pharmaceuticals USA Inc.
Start Date
2016-09-02
Trial ID
NCT02932878
Treatments Being Tested
Efficacy and Safety of DSXS (Taro Pharmaceuticals, U.S.A., Inc.) in Patient...
Status
Completed
Location
Taro Pharmaceuticals USA Inc.
Start Date
2015-09-04
Trial ID
NCT02595073